tm
Seeing Is Believing
tm
Seeing Is Believing
CASI is currently covered by 1 analysts
CASI Pharmaceuticals's activity chart (see below) currently has 12 price targets and 17 ratings on display. The stock rating distribution of CASI is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 28.57% with an average time for these price targets to be met of 108.75 days.
Highest price target for CASI is $2, Lowest price target is $2.
Most recent stock forecast was given by SEAN LEE from HC WAINWRIGHT on 03-Sep-2025. First documented stock forecast 24-Mar-2020.
Currently out of the existing stock ratings of CASI, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-May-2023
$4
$2.98 (292.16%)
$4
1 years 1 months 23 days ago
(03-Sep-2025)
1/7 (14.29%)
$1.67 (71.67%)
54
Buy Since 17-May-2021
$4
3 years 11 months 10 days ago
(16-Nov-2022)
1/2 (50%)
$0.72 (21.95%)
73
Buy Since 24-Mar-2020
$12
$10.98 (1076.47%)
4 years 2 months 11 days ago
(15-Aug-2022)
1/2 (50%)
$7.98 (198.51%)
308
Buy
$50
4 years 5 months ago
(26-May-2022)
0/1 (0%)
$32.3 (182.49%)
What is CASI (CASI Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on CASI (CASI Pharmaceuticals)?
Which analyst has the current lower performing score on CASI (CASI Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CASI (CASI Pharmaceuticals)?
Which analyst is the currently most bullish on CASI (CASI Pharmaceuticals)?
Which analyst is the currently most reserved on CASI (CASI Pharmaceuticals)?
